Frontlight ResearchEarly access
Trial site
Austin Cancer Centers-Central Austin
- 2running trials
- 1closed trial
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Cervical cancer1 trial
- Glioblastoma1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 32 trials
- Phase 21 trial
- Status
- Active, not recruiting2 trials
- Completed1 trial
- Lead sponsor
- GOG Foundation1 trial
- National Cancer Institute (NCI)1 trial
- NRG Oncology1 trial
Running trials
Active, not recruiting
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
Active, not recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026